The US Food and Drug Administration recently published an alert regarding Boston Scientific’s Watchman product, a heart ...

Reprieve Cardiovascular has closed an oversubscribed Series B financing round, raising $61m, for the trial of the Reprieve ...

The rise of agentic artificial intelligence (AI) is liable to have multiple use cases for healthcare in patient-facing areas ...

Conformal has completed a Series D extension financing round, securing $32m to support its clinical trial of the CLAAS ...

Patient demonstrations, ongoing clinical trials and heavy investment signal that BCIs could be commercialised by 2030.

HeartFlow’s $364m initial public offering (IPO) signals market validation for the use artificial intelligence (AI) in a ...

The SEMR JV between Interventional Systems and HICREN has obtained approval for the Intelligent SpinePecker spinal surgical ...

Drug distributor Cardinal Health has signed a $1.9bn agreement to acquire a majority stake in Solaris Health from Lee Equity ...

SetPoint Medical has secured $140m in private financing to accelerate the commercialisation of its SetPoint System, a ...

The US Food and Drug Administration (FDA) has granted approval for Thermo Fisher Scientific’s Oncomine Dx Target Test as a treatment for non-small cell lung cancer (NSCLC). The test serves as a ...

Singapore-based HistoIndex has launched a new artificial intelligence (AI)-based laboratory developed test (LDT) in the US for measuring fibrosis in patients with metabolic dysfunction-associated ...

SetPoint Medical has secured $140m through private financing, earmarked for the commercial rollout of the SetPoint System.